FindTrial
Sign In

A medical records based Real World Study for Therapeutic Drugs Used in ARDS

Evidence-based Study of Therapeutic Drugs Used in ARDS from the Real World Big Data

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035702
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

Treatment Group 1:Ulinastatin
Treatment Group 2:Vitamin C
Treatment Group 3:Hormonal drugs
Control Group:None

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) ARDS cases occurred during hospitalization from 2010 to 2019; (2) >=18 years

Exclusion criteria

Exclusion criteria: 1. Cases of death within 24 hours after admission; 2. Past severe heart, liver, and renal insufficiency, chronic lung disease, organ transplantation, adrenal gland disease, malignant tumor or other immune diseases, severe arrhythmia, heart origin Sexual shock, use immunosuppression or hormones within 3 months, pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
28d mortality;Length of Mechanical ventilation;Length of staying in ICU;—

Secondary

MeasureTime frame
APECH II Score;Change of CRP;—

Countries

China

Contacts

Public ContactChen Wansheng

Shanghai Changzheng Hospital

chenws126@126.com+86 021-81886181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026